ONCOGENLDX Trademark

Trademark Overview

On Wednesday, October 15, 2025, a trademark application was filed for ONCOGENLDX with the United States Patent and Trademark Office. The USPTO has given the ONCOGENLDX trademark a serial number of 99444749. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, October 15, 2025. This trademark is owned by Circulogene Theranostics, Inc.. The ONCOGENLDX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical testing for diagnostic or treatment purposes in the field of analyzing genes for identifying genetic and genomic alterations in cancer
oncogenldx

General Information

Serial Number99444749
Word MarkONCOGENLDX
Filing DateWednesday, October 15, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, October 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical testing for diagnostic or treatment purposes in the field of analyzing genes for identifying genetic and genomic alterations in cancer

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 15, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCirculogene Theranostics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHomewood, AL 35209

Trademark Events

Event DateEvent Description
Wednesday, October 15, 2025NEW APPLICATION ENTERED
Wednesday, October 15, 2025APPLICATION FILING RECEIPT MAILED
Friday, October 17, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

oncogenldx genetic identifying genomic alterations cancer genes analyzing diagnostic testing treatment